Skip to main content
Smart Investors Daily
Cencora, Inc. logo

NYSE · COR

Cencora, Inc.

Healthcare · Medical - Distribution

$348.31

Down-$7.06 (-2.03%)

Updated Nov 20, 2026, 1:15 AM

SID Score

5.9/10

Composite research score

Smart Money

58/100

Neutral

Market cap
66.71B
P/E ratio
42.94
Dividend yield
0.65%
52-week range
$244.82 – $376.92
Volume
1.37M
Avg. volume
1.54M

Price performance · COR

COR price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 18, 2026

COR closed at $348.31 after 20 trading sessions, up 2.90% for the selected period.

Last close
$348.31
Period change
+2.90%
Period low
$324.35
Period high
$359.03
Daily close
View OHLC price history
COR OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 18, 2026$347.16$349.84$344.4926$348.311.37M
Nov 17, 2026$353.05$357.28$349.69$350.561.35M
Nov 16, 2026$362.59$363.50$355.9023$356.941.21M
Nov 13, 2026$351.12$359.39$350.11$359.031.39M
Nov 12, 2026$352.95$354.84$348.68$349.38997.75K
Nov 11, 2026$345.67$350.17$344.50$349.88845.65K
Nov 10, 2026$347.00$350.17$342.60$348.711.08M
Nov 9, 2026$338.58$347.41$336.547$345.761.94M
Nov 6, 2026$333.61$338.535$332.67$333.561.68M
Nov 5, 2026$359.87$363.9461$337.51$339.682.49M
Nov 4, 2026$342.20$355.64$336.72$354.002.89M
Nov 3, 2026$335.90$342.09$334.305$340.501.65M
Nov 2, 2026$333.26$338.19$329.15$337.841.51M
Oct 30, 2026$336.79$340.19$330.20$330.841.35M
Oct 29, 2026$328.84$331.07$326.335$330.531.03M
Oct 28, 2026$321.82$327.43$320.06$324.351.08M
Oct 27, 2026$327.77$330.15$325.00$325.371.12M
Oct 26, 2026$331.60$335.45$329.1701$330.00993.48K
Oct 23, 2026$337.15$338.07$330.31$331.001.17M
Oct 22, 2026$344.43$344.43$337.11$338.481.18M

Latest COR news

The latest Smart Investors Daily articles mentioning COR.

COR research

Overview

Company profile and research snapshot.

Company profile

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$373.17
Implied upside
—
Analysts
14
COR recent ratings
DateFirmRatingTarget
Nov 18, 2026BarclaysOverweight—
Nov 17, 2026Wells FargoOverweight—
Nov 10, 2026JP MorganOverweight—
Nov 5, 2026Leerink PartnersOutperform—
Nov 5, 2026Evercore ISI GroupOutperform—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.